Document de presse
2025.09.29
The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from...
News
2025.09.22
Human African trypanosomiasis, commonly known as sleeping sickness, is characterized by symptoms ranging from severe fatigue and skin signs to sleep...
Vidéo
2025.08.28
Two smells, one molecule. It's just reversed!
Jeanne Fenouil, science writer at the Institut Pasteur, explains how a simple reversal can change everything....
News
2025.07.22
On June 12-13, 2025, the Institut Pasteur hosted the first international conference on the risks and challenges associated with the creation of what are...
News
2025.06.03
Of every one thousand individuals living with HIV, a tiny fraction – fewer than five on average – are able to naturally control the virus. They are known as "...
News
2025.04.22
In early April 2025, a case of mpox was reported in the United Kingdom – and the patient had not been to Africa or come into contact with other infected...
News
2025.03.20
Here is the story of a successful international collaboration. The Institut Pasteur and the Quantitative Biosciences Institute at the University of...
Document de presse
2025.01.31
Guinea celebrates today the elimination of sleeping sickness (also known as human African trypanosomiasis or HAT) as a public health problem.
Despite health...
Document de presse
2024.12.06
Scientists from the National Reference Center for Vibrios and Cholera at the Institut Pasteur, in collaboration with the Centre hospitalier de Mayotte, have...
News
2024.11.29
As well as an anesthetic, some surgeries also require the administration of a neuromuscular blocking agent (NMBA), a drug that induces paralysis, to...